| Sabharwal A, Waters R, Danson S, et al.
Predicting the myelotoxicity of chemotherapy: the use of pretreatment O6-methylguanine-DNA methyltransferase determination in peripheral blood mononuclear cells. [JOURNAL ARTICLE]
Melanoma Res 2009 Jun 25.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Khammari A, Labarrière N, Vignard V, et al.
Treatment of Metastatic Melanoma with Autologous Melan-A/Mart-1-Specific Cytotoxic T Lymphocyte Clones. [JOURNAL ARTICLE]
J Invest Dermatol 2009 Jun 25.
Abstract | Full Citation |
| Sher DJ, Mauch PM, Van Den Abbeele A, et al.
Prognostic significance of mid- and post-ABVD PET imaging in Hodgkin's lymphoma: the importance of involved-field radiotherapy. [JOURNAL ARTICLE]
Ann Oncol 2009 Jun 18.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Weber JS, Zarour H, Redman B, et al.
Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma. [JOURNAL ARTICLE]
Cancer 2009 Jun 17.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Beneduci A
Evaluation of the Potential In Vitro Antiproliferative Effects of Millimeter Waves at Some Therapeutic Frequencies on RPMI 7932 Human Skin Malignant Melanoma Cells. [JOURNAL ARTICLE]
Cell Biochem Biophys 2009 Jun 18.
Abstract | Full Citation |
| González Astorga B, Jiménez Rubiano B, Delgado Pérez JR, et al.
Biochemotherapy in the treatment of metastatic melanoma in selected patients. [Journal Article]
Clin Transl Oncol 2009 Jun; 11(6):382-6.
Abstract | Full Citation |
| Azem F, Hasson J, Cohen T, et al.
Retrieval of immature oocytes after chemotherapy for Hodgkin's disease and prolonged ovarian down-regulation with gonadotropin-releasing hormone agonist. [JOURNAL ARTICLE]
Fertil Steril 2009 Jun 12.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Homsi J, Bedikian AY, Kim KB, et al.
Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in cutaneous and mucosal metastatic melanoma patients. [JOURNAL ARTICLE]
Melanoma Res 2009 Jun 10.
Abstract | Full Citation | Find Related Articles |
| Krupitskaya Y, Wakelee HA
Ramucirumab, a fully human mAb to the transmembrane signaling tyrosine kinase VEGFR-2 for the potential treatment of cancer. [Journal Article]
Curr Opin Investig Drugs 2009 Jun; 10(6):597-605.
Abstract | Full Citation |
| Papadopoulos NE, Bedikian A, Ring S, et al.
Phase I/II Study of a Cisplatin-Taxol-Dacarbazine Regimen in Metastatic Melanoma. [JOURNAL ARTICLE]
Am J Clin Oncol 2009 Jun 5.
Abstract | Full Citation | Find Related Articles |
  |
